LON:OVB - Ovoca Bio Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ovoca Bio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 8 0.00 (0.00 %) (As of 03/27/2020 04:00 PM ET) Add Compare Today's Range 8Now: GBX 8▼ 850-Day Range 6.75MA: GBX 9.73▼ 11.5052-Week Range 5.55Now: GBX 8▼ 29.94VolumeN/AAverage VolumeN/AMarket Capitalization£6.53 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ovoca Bio plc focuses on development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing Libicore, a medication for treatment of female sexual dysfunction. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was founded in 1985 and is based in Dublin, Ireland.Read More Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:OVB Previous Symbol CUSIPN/A CIKN/A Webhttp://www.ovocabio.com/ Phone353 1 661 9819Debt Debt-to-Equity Ratio4.80 Current Ratio28.57 Quick Ratio23.52Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 25.70 per share Price / Book0.31Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees6 Outstanding Shares81,563,800Market Cap£6.53 million Next Earnings DateN/A OptionableNot Optionable Receive OVB News and Ratings via Email Sign-up to receive the latest news and ratings for OVB and its competitors with MarketBeat's FREE daily newsletter. LSE:OVB Rates by TradingView Ovoca Bio (LON:OVB) Frequently Asked Questions How has Ovoca Bio's stock been impacted by COVID-19 (Coronavirus)? Ovoca Bio's stock was trading at GBX 9.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, OVB shares have decreased by 13.5% and is now trading at GBX 8. View which stocks have been mosted impacted by Coronavirus. Has Ovoca Bio been receiving favorable news coverage? Press coverage about OVB stock has been trending very positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ovoca Bio earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutOvoca Bio. Who are some of Ovoca Bio's key competitors? Some companies that are related to Ovoca Bio include OptiBiotix Health (OPTI), Oragenics (OGEN), Inhibitor Therapeutics (INTI), e-Therapeutics (ETX), Mereo BioPharma Group (MPH), Oragenics (OGEN), Scancell (SCLP), Rezolute (RZLT), Ixico (IXI), Microbix Biosystems (MBX), Actinogen Medical (ACW), Proteomics Int Lab (PIQ), Aerpio Pharmaceuticals (ARPO), Nuformix (NFX) and Pharmaust (PAA). What other stocks do shareholders of Ovoca Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ovoca Bio investors own include CarMax (KMX), Mitie Group (MTO), Beazer Homes USA (BZH), Chesapeake Lodging Trust (CHSP), Parsley Energy (PE), NEW WORLD DEV L/ADR (NDVLY), Applied Materials (AMAT), S4 Capital (SFOR), PureTech Health (PRTC) and J D Wetherspoon (JDW). Who are Ovoca Bio's key executives? Ovoca Bio's management team includes the following people: Dr. Mikhail Alexandrovich Mogutov Ph.D., Exec. ChairmanMr. Kirill Andreyevich Golovanov, CEO, Company Sec. & Exec. Director (Age 41)Dr. Svetlana Radchenko, Chief Financial Officer What is Ovoca Bio's stock symbol? Ovoca Bio trades on the London Stock Exchange (LON) under the ticker symbol "OVB." How do I buy shares of Ovoca Bio? Shares of OVB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Ovoca Bio's stock price today? One share of OVB stock can currently be purchased for approximately GBX 8. How big of a company is Ovoca Bio? Ovoca Bio has a market capitalization of £6.53 million. Ovoca Bio employs 6 workers across the globe. View additional information about Ovoca Bio. What is Ovoca Bio's official website? The official website for Ovoca Bio is http://www.ovocabio.com/. How can I contact Ovoca Bio? The company can be reached via phone at 353 1 661 9819. MarketBeat Community Rating for Ovoca Bio (LON OVB)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 17 (Vote Outperform)Underperform Votes: 15 (Vote Underperform)Total Votes: 32MarketBeat's community ratings are surveys of what our community members think about Ovoca Bio and other stocks. Vote "Outperform" if you believe OVB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OVB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/28/2020 by MarketBeat.com StaffFeatured Article: The Role of a Fiduciary and Individual Investors
